Bristol Myers Squibb ROE - Return on Equity 2010-2024 | BMY

Bristol Myers Squibb return on equity for the quarter ending September 30, 2024 was -36.15.

  • Bristol Myers Squibb average return on equity for 2023 was 25.16, a 31.25% decline from 2022.
  • Bristol Myers Squibb average return on equity for 2022 was 19.17, a 444.78% increase from 2021.
  • Bristol Myers Squibb average return on equity for 2021 was -5.56, a 24.38% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Bristol Myers Squibb ROE - Return on Equity 2010-2024 | BMY

  • Bristol Myers Squibb average return on equity for 2023 was 25.16, a 31.25% decline from 2022.
  • Bristol Myers Squibb average return on equity for 2022 was 19.17, a 444.78% increase from 2021.
  • Bristol Myers Squibb average return on equity for 2021 was -5.56, a 24.38% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.